Lumos Diagnostics Holdings Limited
LDXHF
$0.115
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -100.96% | -100.96% | 56.28% | 56.28% | 9.47% |
| Total Depreciation and Amortization | -32.93% | -32.93% | 3.86% | 3.86% | -54.57% |
| Total Amortization of Deferred Charges | -37.25% | -37.25% | -- | -- | 40.60% |
| Total Other Non-Cash Items | 691.53% | 691.53% | -1,846.76% | -1,846.76% | 21.44% |
| Change in Net Operating Assets | -200.41% | -200.41% | -- | -- | 237.53% |
| Cash from Operations | -152.15% | -152.15% | -30.47% | -30.47% | 256.28% |
| Capital Expenditure | 16.28% | 16.28% | -88.89% | -88.89% | 59.43% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -516.67% |
| Cash from Investing | 55.00% | 55.00% | 5.56% | 5.56% | -101.84% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 12.41% | 12.41% | 75.52% | 75.52% | 20.98% |
| Issuance of Common Stock | -- | -- | 26.40% | 26.40% | -- |
| Repurchase of Common Stock | -53.82% | -53.82% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 53.82% | 53.82% | -53.82% | -53.82% | 363.43% |
| Cash from Financing | 12.41% | 12.41% | 80.19% | 80.19% | -133.20% |
| Foreign Exchange rate Adjustments | 48.15% | 48.15% | -3,161.54% | -3,161.54% | 83.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -170.12% | -170.12% | 42.11% | 42.11% | 128.49% |